|
|
|
|
| LEADER |
02932nam a2200529Ia 4500 |
| 001 |
10.3390-molecules27072219 |
| 008 |
220425s2022 CNT 000 0 und d |
| 020 |
|
|
|a 14203049 (ISSN)
|
| 245 |
1 |
0 |
|a Anti-Cancer Activity of Buthus occitanus Venom on Hepatocellular Carcinoma in 3D Cell Culture
|
| 260 |
|
0 |
|b MDPI
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3390/molecules27072219
|
| 520 |
3 |
|
|a Hepatocellular carcinoma (HCC) is the most dominant primary liver cancer, which can be caused by chronic hepatitis virus infections and other environmental factors. Resection, liver transplantation, and local ablation are only a few of the highly effective and curative procedures presently accessible. However, other complementary treatments can reduce cancer treatment side effects. In this present work, we evaluated the activity of Moroccan scorpion venom Buthus occitanus and its fractions obtained by chromatography gel filtration against HCC cells using a 3D cell culture model. The venom was fractionated by gel filtration chromatography, each fraction and the crude venom was tested on normal hepatocytes (Fa2N-4 cells). Additionally, the fractions and the crude venom were tested on MCTSs (multicellular tumor spheroids), and this latter was generated by cultivate Huh7.5 cancer cell line with WI38 cells, LX2 cells, and human endothelial cells (HUVEC). Our results indicate that Buthus occitanus venom toxin has no cytotoxic effects on normal hepatocytes. Moreover, it is reported that F3 fraction could significantly inhibit the MCTS cells. Other Protein Separation Techniques (High-performance liquid chromatography) are needed in order to identify the most active molecule. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
|
| 650 |
0 |
4 |
|a animal
|
| 650 |
0 |
4 |
|a Animals
|
| 650 |
0 |
4 |
|a anticancer activity
|
| 650 |
0 |
4 |
|a Buthus occitanus
|
| 650 |
0 |
4 |
|a Carcinoma, Hepatocellular
|
| 650 |
0 |
4 |
|a Cell Culture Techniques, Three Dimensional
|
| 650 |
0 |
4 |
|a chemistry
|
| 650 |
0 |
4 |
|a Chromatography, High Pressure Liquid
|
| 650 |
0 |
4 |
|a Endothelial Cells
|
| 650 |
0 |
4 |
|a endothelium cell
|
| 650 |
0 |
4 |
|a hepatocellular carcinoma
|
| 650 |
0 |
4 |
|a high performance liquid chromatography
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a Humans
|
| 650 |
0 |
4 |
|a liver cell carcinoma
|
| 650 |
0 |
4 |
|a Liver Neoplasms
|
| 650 |
0 |
4 |
|a liver tumor
|
| 650 |
0 |
4 |
|a multicellular tumor spheroids
|
| 650 |
0 |
4 |
|a scorpion
|
| 650 |
0 |
4 |
|a scorpion venom
|
| 650 |
0 |
4 |
|a Scorpion Venoms
|
| 650 |
0 |
4 |
|a Scorpions
|
| 650 |
0 |
4 |
|a venom
|
| 700 |
1 |
|
|a Cadi, R.
|e author
|
| 700 |
1 |
|
|a Chakir, S.
|e author
|
| 700 |
1 |
|
|a Daoudi, K.
|e author
|
| 700 |
1 |
|
|a Darkaoui, B.
|e author
|
| 700 |
1 |
|
|a Heo, J.-Y.
|e author
|
| 700 |
1 |
|
|a Lafnoune, A.
|e author
|
| 700 |
1 |
|
|a Lee, S.-Y.
|e author
|
| 700 |
1 |
|
|a Mounaji, K.
|e author
|
| 700 |
1 |
|
|a Oukkache, N.
|e author
|
| 700 |
1 |
|
|a Seo, H.-R.
|e author
|
| 700 |
1 |
|
|a Shum, D.
|e author
|
| 773 |
|
|
|t Molecules
|
